IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,152,355 | -13.4% | 119,663 | -4.3% | 0.00% | 0.0% |
| Q2 2023 | $1,330,298 | -3.8% | 125,028 | -4.9% | 0.00% | 0.0% |
| Q1 2023 | $1,383,233 | -23.7% | 131,486 | -10.2% | 0.00% | -33.3% |
| Q4 2022 | $1,813,908 | +12.9% | 146,401 | -5.6% | 0.01% | +20.0% |
| Q3 2022 | $1,606,000 | -15.7% | 155,007 | -6.2% | 0.01% | 0.0% |
| Q2 2022 | $1,905,000 | -29.5% | 165,227 | -23.1% | 0.01% | -16.7% |
| Q1 2022 | $2,702,000 | +7.9% | 214,800 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $2,505,000 | -10.7% | 214,800 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $2,805,000 | +1.5% | 214,800 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $2,764,000 | +15.1% | 214,800 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $2,401,000 | -7.1% | 214,800 | -5.3% | 0.01% | -16.7% |
| Q4 2020 | $2,584,000 | +12.5% | 226,900 | -11.1% | 0.01% | 0.0% |
| Q3 2020 | $2,296,000 | -12.8% | 255,200 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $2,634,000 | +10.1% | 255,200 | +7.6% | 0.01% | -12.5% |
| Q1 2020 | $2,392,000 | -21.8% | 237,100 | +3.2% | 0.01% | 0.0% |
| Q4 2019 | $3,059,000 | +45.5% | 229,800 | -6.1% | 0.01% | +33.3% |
| Q3 2019 | $2,102,000 | -6.0% | 244,800 | +19.8% | 0.01% | 0.0% |
| Q2 2019 | $2,236,000 | -12.0% | 204,400 | +8.9% | 0.01% | -14.3% |
| Q1 2019 | $2,540,000 | -35.0% | 187,700 | -50.2% | 0.01% | -46.2% |
| Q4 2018 | $3,906,000 | -51.4% | 377,030 | -13.3% | 0.01% | -40.9% |
| Q3 2018 | $8,031,000 | -3.5% | 435,030 | 0.0% | 0.02% | -8.3% |
| Q2 2018 | $8,318,000 | -6.8% | 435,030 | -24.8% | 0.02% | -7.7% |
| Q1 2018 | $8,921,000 | -29.7% | 578,130 | -31.7% | 0.03% | -25.7% |
| Q4 2017 | $12,694,000 | +10.1% | 846,800 | +15.8% | 0.04% | +2.9% |
| Q3 2017 | $11,528,000 | -1.7% | 731,000 | +17.7% | 0.03% | -10.5% |
| Q2 2017 | $11,724,000 | +174.9% | 621,000 | +148.4% | 0.04% | +137.5% |
| Q1 2017 | $4,265,000 | -0.4% | 250,000 | -10.7% | 0.02% | -11.1% |
| Q4 2016 | $4,281,000 | -55.1% | 280,000 | -53.3% | 0.02% | -52.6% |
| Q3 2016 | $9,528,000 | -54.7% | 600,000 | -62.7% | 0.04% | -55.3% |
| Q2 2016 | $21,049,000 | -20.5% | 1,609,897 | -33.5% | 0.08% | -17.5% |
| Q1 2016 | $26,474,000 | -24.9% | 2,419,897 | -20.4% | 0.10% | -24.3% |
| Q4 2015 | $35,253,000 | -12.5% | 3,041,686 | -21.3% | 0.14% | -12.3% |
| Q3 2015 | $40,267,000 | -32.7% | 3,864,380 | -22.1% | 0.16% | -26.2% |
| Q2 2015 | $59,793,000 | +20.2% | 4,957,980 | +59.5% | 0.21% | +22.1% |
| Q1 2015 | $49,728,000 | -12.9% | 3,107,980 | -16.6% | 0.17% | -12.2% |
| Q4 2014 | $57,120,000 | -9.5% | 3,728,485 | -23.5% | 0.20% | -14.4% |
| Q3 2014 | $63,136,000 | -13.4% | 4,873,497 | +2.5% | 0.23% | -12.6% |
| Q2 2014 | $72,902,000 | -6.1% | 4,755,497 | -24.5% | 0.26% | -11.5% |
| Q1 2014 | $77,616,000 | +8.5% | 6,300,000 | +2.2% | 0.30% | +7.6% |
| Q4 2013 | $71,554,000 | +13.9% | 6,163,095 | +16.3% | 0.28% | +5.8% |
| Q3 2013 | $62,805,000 | +43.5% | 5,299,980 | +20.5% | 0.26% | +42.1% |
| Q2 2013 | $43,780,000 | – | 4,399,980 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |